BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies

Journal of Gastrointestinal Oncology

Callisia N. Clarke¹  E. Scott Kopetz² 

[1] Department of Surgical Oncology,The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USADepartment of Surgical Oncology,The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USADepartment of Surgical Oncology,The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA;Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USADepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USADepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

关键词: Colorectal cancer (CRC);    BRAF;    prognostic biomarker;    targeted therapy;   

DOI  :  10.3978/j.issn.2078-6891.2015.077

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown